Queen's 'secures' £25m for UK's cy...(CIT will develop secure solutions to a n...)

Date:11/20/2008

CIT will develop secure solutions to a number of particularly modern problems including the protection of mobile phone networks, guaranteeing privacy over unsecure networks for connected healthcare and the creation of secure 'corridors' for the seamless and rapid transit of people, thus getting around the need for conventional security at airports."

Queen's is also working on powerful computer processors capable of detecting and filtering viruses and worms to protect mass information databases like financial records from malicious attack and to facilitate high definition streaming video services.

Professor McCanny added: "Although only four years old, ECIT has already achieved many world-class scientific breakthroughs and helped create many new spin-out companies. The new Centre will realise the full potential of emerging technologies, ensuring Queen's and the UK is the first to develop such cutting-edge research."

UK Minister of State for Science and Innovation, Lord Drayson, said "More public money than ever before is being spent on world leading research into the strategic challenges facing the UK such as the world's ageing population and security.

"The investment in these two new Innovation and Knowledge Centres will foster an entrepreneurial environment where ground-breaking research can mix at an early stage with business and potential customers, to provide a clear commercial strategy for accelerating its impact on the economy. This is exactly what the UK needs."

'/>"/>

Contact: Andrea Clements a.clements@qub.ac.uk Queen's University Belfast Source:Eurekalert

1 GOOD

Page: 1 2
Related biology technology :

1. Xenome Receives a Syndicated US$10 Million Equity Investment from Queensland BioCapital Fund, Amylin Pharmaceuticals and Innovis Investment Partners
2. Open Biosystems Open Access RNAi Program Adopted by University of Copenhagen and University of Queensland
3. Microchip Biotechnologies, Inc. Secures Exclusive License to Use New University of Alberta Technology for Developing Microfluidic Devices
4. Hyperion Therapeutics Secures $40 Million In Series B Round
5. Weil Gotshal Wins Major Victory for Applera; Secures Summary Judgment Invalidating Three Patents
6. Altheus Therapeutics Secures $3.6 Million in Venture Capital
7. Apollo Endosurgery, Inc. Secures $11.5 Million in Series A Financing.
8. Dendreon Secures $130 Million Committed Equity Financing Facility
9. Neptune Technologies & Bioressources Inc. Secures Access to Nationwide Consumer Mass Market in the United States
10. Taligen Therapeutics Secures Series B Financing
11. Halogen Announces Record Year - Company Solidifies Leadership Position, Secures Strategic Wins Over Competition